Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Interim Management Statement

19 Sep 2012 07:00

RNS Number : 5561M
PZ CUSSONS PLC
19 September 2012
 



19 September 2012

PZ Cussons Plc

(the "Group")

 

Interim Management Statement

 

PZ Cussons Plc, a leading international consumer products group, today issues the following interim management statement which covers the period 1 June 2012 to 18 September 2012, in advance of its Annual General Meeting, to be held at 10:30 today.

 

Overview of financial performance and position

 

The board is pleased to announce that the performance of the Group during the period has been in line with management expectations. The financial position of the Group remains strong with cash generation during the period also in line with expectations.

 

Trading Update

 

Europe

 

In the UK, trading in the washing and bathing division has been robust despite continued high levels of promotional activity in the trade. New product launches remain key to driving differentiation and attracting consumers and the next few months will see the launch of new Imperial Leather limited edition shower and bath products, and a new seasonal edition of Original Source.

 

Cussons Mum and Me, the new range of products for mother and baby, achieved full UK distribution by the end of July and an extensive media campaign began in the middle of August. Early sales rates are encouraging.

 

In the beauty division, whilst the poor summer weather adversely impacted sales of St Tropez, the other brands in the portfolio have performed well with Sanctuary benefiting from the launch of the new Active Reverse skin care range with ballet star Darcey Bussell as brand ambassador. Further new product launches for both UK and International markets are planned during the remainder of the calendar year.

 

Performance in Poland has been strong whilst trading conditions in Greece remain difficult.

 

Asia

 

The positive momentum in Indonesia has continued with further growth in revenue and profitability during the period.

 

Whilst trading conditions in Australia remain challenging, the measures taken to improve the performance of the business continue to be successfully implemented. The production facility has now closed as part of the move to a variable cost model and the business as a whole is trading profitably.

 

Africa

 

In Nigeria, the two key issues affecting the performance of the business have remained. Unrest in the north of the country has continued to affect sales rates and consumer disposable income remains affected by the removal of part of the fuel subsidy in January. More positively however, margins have improved as a result of lower raw material costs and margin improvement projects.

 

Construction of the palm oil refinery with Wilmar in Nigeria is on track with completion due by the end of the calendar year.

 

Outlook

 

Trading conditions in most markets remain challenging as a result of general uncertainty regarding the global economic outlook and pressures on consumer disposable income from high food and fuel prices. The situation in the Group's important Nigerian market continues to be fragile although the longer term opportunity remains exciting.

 

The Group's focus remains on new product development and further margin improvement. Raw material cost trends are expected to be favourable this year and the benefits of the supply chain optimisation project are also beginning to be seen.

 

The Board remains confident of a return to profitable growth in the current financial year.

 

A further trading update will be made on 6 December 2012.

 

Enquiries:

 

PZ Cussons Plc

Brandon Leigh Tel: 0161 435 1236

 

MHP Communications

John Olsen / James White Tel: 020 3128 8100

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBKFDPNBKDKCD
Date   Source Headline
29th Nov 202111:25 amRNSDirector/PDMR Shareholding
25th Nov 20214:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:05 pmRNSAnnual General Meeting
9th Nov 20217:00 amRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSPublication of Annual Report and notice of AGM
24th Sep 20219:00 amRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading Statement
22nd Sep 20217:00 amRNSFinal Results
13th Sep 20213:00 pmRNSAppointment of Non Executive Director
27th Jul 202111:00 amRNSDirector/PDMR Shareholding
5th Jul 20214:00 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTrading update
29th Jun 202110:45 amRNSNotice of pre-close trading update
25th Jun 20217:00 amRNSAppointment of Non Executive Director
27th Apr 20217:00 amRNSTrading Statement
25th Mar 20217:00 amRNSCapital Markets Day
22nd Mar 20211:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20215:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20219:00 amRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSHalf-year Report
1st Dec 20203:45 pmRNSDirector/PDMR Shareholding
26th Nov 20202:30 pmRNSResult of AGM
26th Nov 20207:00 amRNSDirectorate Change
23rd Oct 202012:00 pmRNSPublication of Annual Report / Notice of AGM
20th Oct 20201:00 pmRNSHolding(s) in Company
1st Oct 20208:38 amRNSCompletion of Nutricima disposal
28th Sep 20203:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:00 amRNSTrading Statement
23rd Sep 20207:00 amRNSBoard Change
23rd Sep 20207:00 amRNSFinal Results for the year ended 31 May 2020
14th Aug 20208:50 amRNSDirector Declaration
6th Jul 20209:05 amRNSDirector Declaration
30th Jun 20205:30 pmRNSDirector/PDMR Shareholding
19th Jun 20209:29 amRNSDirector/PDMR Shareholding
5th Jun 20202:15 pmRNSRevised reporting timetable
28th May 20201:01 pmRNSDirector/PDMR Shareholding
22nd May 202010:20 amRNSDirector Declaration
28th Apr 202011:33 amRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSTrading Update for the Third Quarter 2020
14th Apr 20204:15 pmRNSBoard Change
2nd Apr 20207:00 amRNSUpdate on Settlement Agreement with Former CEO
19th Mar 20207:00 amRNSAppointment of new Chief Executive Officer
19th Mar 20207:00 amRNSBoard changes
18th Mar 20207:00 amRNSSale of Nutricima and completion of Luksja sale
20th Feb 20207:00 amRNSHolding(s) in Company
28th Jan 20207:00 amRNSHalf-year Report
12th Dec 20197:00 amRNSDirectorate Change
12th Dec 20197:00 amRNSTrading Update
30th Oct 20197:00 amRNSAppointment of Non-executive Directors
30th Sep 201911:15 amRNSCompletion of Minerva sale

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.